A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

Clinical trial NCT06285318 · RECRUITING

Trial details

NCT number: NCT06285318
Sponsor: Janssen-Cilag Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsed/Refractory Multiple Myeloma (RRMM)

Start date: 2023-12-18
Primary completion: 2026-08-30
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.